MAP
KRSA

Madison Avenue Partners’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Madison Avenue Partners’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-947
Closed -$361K – 22
2019
Q4 		$361K Buy
+947
New +$88.4K 0.31% 14

Other funds holding KRSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return

Madison Avenue Partners's KRSA Position: Q1 2020 in Review

Madison Avenue Partners sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2020, closing a stake of 947 shares — an estimated $361K sold.

Madison Avenue Partners first reported a position in KRSA in Q4 2019 and held it in 1 quarter. The position peaked at $361K in Q4 2019. 74 funds tracked by Wall St. Rank hold KRSA as of Q1 2020.

  • Madison Avenue Partners reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Madison Avenue Partners sold 947 Korsana Biosciences, Inc. Common Stock shares in Q1 2020, an estimated $361K.
  • Madison Avenue Partners first reported a position in Korsana Biosciences, Inc. Common Stock in Q4 2019 and held it in 1 quarter.
  • Madison Avenue Partners's Korsana Biosciences, Inc. Common Stock position peaked at $361K in Q4 2019.
  • 74 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2020.

Based on Madison Avenue Partners's 13F filing for Q1 2020, filed 15 May 2020.